The Vanguard Group 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,802,081 7.990% |
213,159 (+5.94%) |
Filing |
| 2023-02-09 11:30 am Sale |
2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,588,922 7.860% |
-91,265 (-2.48%) |
Filing |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,680,187 9.000% |
283,498 (+8.35%) |
Filing |
| 2021-02-10 11:40 am Sale |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,396,689 8.540% |
-589,437 (-14.79%) |
Filing |